检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:徐成波[1] 郑瑞玑 沈建箴[3] 廖斌[1] 齐彦[1] 陈泽松 Xu Chengbo;Zheng Ruiji;Shen Jianzhen;Liao Bin;Qi Yan;Chen Zesong(Department of Hematology,the Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine,Fujian Provincial People's Hospital,Fuzhou 350004,China;Department of Hematology,Zhangzhou Affiliated Hospital of Fujian Medical University,Zhangzhou 363000,China;Department of Hematology,Fujian Medical University Union Hospital,Fujian Institute of Hematology,Fuzhou 350001,China)
机构地区:[1]福建省人民医院,福建中医药大学附属人民医院血液科,福州350004 [2]福建医科大学附属漳州市医院血液科,漳州363000 [3]福建医科大学附属协和医院血液科,福建省血液病研究所,福州350001
出 处:《白血病.淋巴瘤》2022年第6期353-356,共4页Journal of Leukemia & Lymphoma
基 金:福建省自然科学基金(2021J01897);福建省教育厅中青年教师教育科研项目(JAT200215)。
摘 要:目的探讨慢性淋巴细胞白血病患者肾脏受累的临床表现、诊断和治疗。方法回顾性分析2020年10月福建省人民医院收治的1例以肾病综合征为初始表现的慢性淋巴细胞白血病患者的临床资料,并复习相关文献。结果患者为68岁男性,以反复全身水肿、泡沫尿为初始表现,就诊肾内科诊断为肾病综合征,治疗后未见明显改善并逐渐出现淋巴细胞增高,就诊血液科确诊为慢性淋巴细胞白血病。应用伊布替尼单药治疗后淋巴细胞计数和尿蛋白逐渐降至正常,随访结束患者临床疗效评价为完全缓解。结论以肾病综合征为初始表现的慢性淋巴细胞白血病较为罕见,临床异质性较大,尽早诊断是治疗成功的保障,一线Bruton酪氨酸激酶抑制剂单药治疗的效果和安全性较好。Objective To investigate the clinical manifestation,diagnosis and treatment of chronic lymphocytic leukemia patients with renal involvement.Methods The clinical data of a chronic lymphocytic leukemia patient with nephrotic syndrome as the initial manifestation in Fujian Provincial People's Hospital in October 2020 were retrospectively analyzed,and the related literature was reviewed.Results The patient was a 68-year-old male with recurrent edema and foam urine as the initial manifestations,and he was diagnosed as nephrotic syndrome in the nephrology department.After treatment,the symptoms showed no significant improvement,and the lymphocyte count gradually increased.The patient was diagnosed as chronic lymphocytic leukemia in the hematology department.After ibrutinib monotherapy,the lymphocyte count and urine protein gradually decreased to normal levels,and the clinical efficacy evaluation of the patient was complete remission at the end of follow-up.Conclusions Chronic lymphocytic leukemia with nephrotic syndrome as the initial manifestation is rare,and the clinical presentations are variable.Early diagnosis is the guarantee of successful treatment.The efficacy and safety of first-line Bruton tyrosine kinase inhibitor monotherapy are good.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.222